{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:50Z","timestamp":1791828590596,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jlr.2024.100651","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:55:18Z","timestamp":1726793718000},"page":"100651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A specific serum lipid signature characterizes patients with glycogen storage disease type Ia"],"prefix":"10.1016","volume":"65","author":[{"given":"Alessandro","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0150-0202","authenticated-orcid":false,"given":"Francesca","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-7833","authenticated-orcid":false,"given":"Maaike H.","family":"Oosterveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry G.J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-8213","authenticated-orcid":false,"given":"Marianna","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100651_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.jlr.2024.100651_bib2","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3390\/nu13113828","article-title":"Glycogen storage disease type Ia: current management options, burden and unmet needs","volume":"13","author":"Derks","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jlr.2024.100651_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jimd.12386","article-title":"A\u00a0generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: a retrospective, single-center study and the generation of www.emergencyprotocol.net","volume":"44","author":"Rossi","year":"2021","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","article-title":"Hepatocellular carcinoma in glycogen storage disease type Ia: a case series","volume":"28","author":"Franco","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jpeds.2014.12.015","article-title":"Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study","volume":"166","author":"Melis","year":"2015","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jlr.2024.100651_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10545-018-0149-4","article-title":"Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?","volume":"41","author":"Rossi","year":"2018","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13023-020-01377-w","article-title":"Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement","volume":"15","author":"Rossi","year":"2020","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib8","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jlr.2024.100651_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mpd.2002.121382","article-title":"Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a","volume":"140","author":"Bandsma","year":"2002","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jlr.2024.100651_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1203\/PDR.0b013e31816c9013","article-title":"Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a","volume":"63","author":"Bandsma","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jlr.2024.100651_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jimd.12380","article-title":"Impaired very-low-density lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in glycogen storage disease type Ia","volume":"44","author":"Hoogerland","year":"2021","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib12","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF02679998","article-title":"Disturbed lipid metabolism in glycogen storage disease type 1","volume":"161","author":"Bandsma","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jlr.2024.100651_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10545-017-0039-1","article-title":"Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control","volume":"40","author":"Peeks","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00431-006-0372-0","article-title":"Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk","volume":"166","author":"Nagasaka","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jlr.2024.100651_bib15","article-title":"High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia","volume":"4","author":"Haring","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jlr.2024.100651_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10545-015-9811-2","article-title":"Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions","volume":"38","author":"Derks","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ymgme.2018.07.003","article-title":"Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I \u2013 A link to metabolic control","volume":"125","author":"Hornemann","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2024.100651_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jimd.12451","article-title":"Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I","volume":"45","author":"Mathis","year":"2022","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cell.2010.11.033","article-title":"Lipidomics: new tools and applications","volume":"143","author":"Wenk","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2024.100651_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154005","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jlr.2024.100651_bib21","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00125-016-4024-2","article-title":"MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study","volume":"59","author":"von Toerne","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2024.100651_bib22","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.3390\/ijms22179548","article-title":"The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism","volume":"22","author":"Caterino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100651_bib23","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","article-title":"Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19","volume":"11","author":"Caterino","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100651_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50735-7","article-title":"A\u00a0phospholipid profile at 4 Months predicts the onset of celiac disease in at-risk infants","volume":"9","author":"Auricchio","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100651_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41598-022-24429-6","article-title":"Lipidomic alterations in human saliva from cystic fibrosis patients","volume":"13","author":"Caterino","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100651_bib26","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/molecules26082397","article-title":"Proteomic and bioinformatic investigation of altered pathways in neuroglobin-deficient breast cancer cells","volume":"26","author":"Costanzo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jlr.2024.100651_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2021.10.003","article-title":"A\u00a0knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I","volume":"134","author":"Gonzalez Melo","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2024.100651_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2021.03.017","article-title":"The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery","volume":"133","author":"Gonzalez Melo","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2024.100651_bib29","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/hep.30778","article-title":"Glucose-6-phosphate regulates hepatic bile acid synthesis in mice","volume":"70","author":"Hoogerland","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2024.100651_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.jlr.2024.100651_bib31","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/s41467-018-05613-7","article-title":"A\u00a0selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism","volume":"9","author":"Turner","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2024.100651_bib32","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with non-alcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.jlr.2024.100651_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12263-023-00729-y","article-title":"Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia","volume":"18","author":"Rossi","year":"2023","journal-title":"Genes Nutr."},{"key":"10.1016\/j.jlr.2024.100651_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00109-021-02076-0","article-title":"Endogenous cortisol excess confers a unique lipid signature and metabolic network","volume":"99","author":"Vega-Beyhart","year":"2021","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.jlr.2024.100651_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10408398.2020.1736510","article-title":"Sphingolipids in food and their critical roles in human health","volume":"61","author":"Wang","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jlr.2024.100651_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-nutr-062220-112920","article-title":"The lard works in mysterious ways: ceramides in nutrition-linked chronic disease","volume":"42","author":"Nicholson","year":"2022","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.jlr.2024.100651_bib37","doi-asserted-by":"crossref","first-page":"E649","DOI":"10.1002\/oby.20508","article-title":"The effect of short-term overfeeding on serum lipids in healthy humans","volume":"21","author":"Heilbronn","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.jlr.2024.100651_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146161","article-title":"Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women","volume":"6","author":"Le Barz","year":"2021","journal-title":"JCI Insight."},{"key":"10.1016\/j.jlr.2024.100651_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jlr.2024.100651_bib40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbalip.2013.11.013","article-title":"Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function","volume":"1841","author":"Hollie","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100651_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0344-0338(80)80185-3","article-title":"Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells","volume":"167","author":"Riede","year":"1980","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jlr.2024.100651_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/srep44408","article-title":"Hepatic mitochondrial dysfunction is a\u00a0feature of glycogen storage disease type Ia (GSDIa)","volume":"7","author":"Farah","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100651_bib43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/humu.20772","article-title":"Mutations in the glucose-6-phosphatase-\u03b1 (G6PC) gene that cause type Ia glycogen storage disease","volume":"29","author":"Chou","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2024.100651_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jimd.12178","article-title":"Research priorities for liver glycogen\u00a0storage disease: an international priority setting partnership with the James Lind Alliance","volume":"43","author":"Peeks","year":"2020","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2024.100651_bib45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmet.2017.12.003","article-title":"Could ceramides become the new cholesterol?","volume":"27","author":"Summers","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100651_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.785124","article-title":"Sphingolipid profiling: a promising tool for stratifying the metabolic syndrome-associated risk","volume":"8","author":"Berkowitz","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jlr.2024.100651_bib47","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/ATVBAHA.120.315530","article-title":"Ceramide scores predict cardiovascular risk in the community","volume":"41","author":"Vasile","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100651_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjcard.2020.04.052","article-title":"Effect of proprotein convertase subtilisin\/kexin type 9 inhibitors on plasma ceramide levels","volume":"128","author":"Ye","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jlr.2024.100651_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100483","volume":"4","author":"East","year":"2022","journal-title":"Kidney Med."},{"key":"10.1016\/j.jlr.2024.100651_bib50","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1111\/liv.14643","article-title":"Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative","volume":"40","author":"Stokman","year":"2020","journal-title":"Liver Int."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T16:15:56Z","timestamp":1735661756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0022227524001561"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100651","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A specific serum lipid signature characterizes patients with glycogen storage disease type Ia","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100651"}}